A new model for open MS discovery invites the brightest minds in the field to interrogate ACP’s longitudinal and multi-omic MS data spanning decades in a single secure environment.

17-Year Multiomics Pioneer Powers Next Era of Precision Health

Enterprise Leading Orchestration Platform Honored for AI-Enabled Infrastructure and Next-Gen Digital Health & Medical Technology

Meet the Discovery Awardees of the Longitude Prize on ALS, awarded £100,000 each, as well as access to the Prize datasets and a technical support package to drive their computational work. These 20 pioneering, global and multidisciplinary teams are using cutting-edge AI to unlock the complexity of ALS.

EpiCypher’s new bioinformatics platform, powered by DNAnexus, accelerates data analysis for leading chromatin mapping technologies including CUT&RUN and CUT&Tag.

DNAnexus earned recognition from Frost & Sullivan for its leadership in precision health informatics. The award highlights its groundbreaking platform for integrating complex clinical, multi-omics, and real-world data to deliver secure, actionable insights.

Collaboration to enable healthcare professionals to access and interpret genomic data alongside patient medical history within Oracle Health EHR.

Company appoints Pieter De Leenheer as Chief Technology Officer and Todd Oakland as Senior Vice President and General Manager of Biopharma Business Dx/Rx

This recognition highlights an emerging model for dynamic, cloud-based regulatory collaboration.

The Longitude Prize on ALS, a £7.5 million global challenge prize, has launched to incentivise and reward cutting edge AI-based approaches to transform drug discovery for the treatment of ALS (amyotrophic lateral sclerosis), the most common form of MND (motor neurone disease).